Angiomyolipoma risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(10 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Angiomyolipoma}}
{{Angiomyolipoma}}
{{CMG}} {{AE}}{{Faizan}}
{{CMG}}; {{AE}} {{Faizan}}, {{Rekha}}
==Overview==
==Overview==
Tuberous sclerosis is a risk factor for the development of angiomyolipoma. Approximately 50% of individuals with tuberous sclerosis develop bilateral angiomyolipomas.
[[Tuberous sclerosis]] is a [[risk factor]] for the development of [[angiomyolipoma]]. Approximately 50% of individuals with [[tuberous sclerosis]] develop bilateral [[Angiomyolipoma|angiomyolipomas]].
==Risk Factors==
==Risk Factors ==
Tuberous sclerosis is a risk factor for the development of angiomyolipoma. Approximately 50% of individuals with tuberous sclerosis develop bilateral angiomyolipomas.
 
=== Common Risk Factors ===
 
 
 
* The most potent [[risk factor]] for the development of [[angiomyolipoma]] includes:<ref name="pmid9628635">{{cite journal| author=Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, Roach ES| title=Renal lesion growth in children with tuberous sclerosis complex. | journal=J Urol | year= 1998 | volume= 160 | issue= 1 | pages= 141-5 | pmid=9628635 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9628635  }}</ref><ref name="pmid12409579">{{cite journal| author=Casper KA, Donnelly LF, Chen B, Bissler JJ| title=Tuberous sclerosis complex: renal imaging findings. | journal=Radiology | year= 2002 | volume= 225 | issue= 2 | pages= 451-6 | pmid=12409579 | doi=10.1148/radiol.2252011584 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12409579  }}</ref><ref name="pmid17003820">{{cite journal| author=Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA| title=Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. | journal=Kidney Int | year= 2006 | volume= 70 | issue= 10 | pages= 1777-82 | pmid=17003820 | doi=10.1038/sj.ki.5001853 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17003820  }}</ref><ref name="pmid96286352">{{cite journal| author=Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, Roach ES| title=Renal lesion growth in children with tuberous sclerosis complex. | journal=J Urol | year= 1998 | volume= 160 | issue= 1 | pages= 141-5 | pmid=9628635 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9628635  }}</ref>
**[[Tuberous sclerosis]]
***Approximately 50% of individuals with [[tuberous sclerosis]] develop bilateral [[Angiomyolipoma|angiomyolipomas]].
**[[Genetics|Genetic]] [[Mutation|mutations]]


==References==
==References==
Line 13: Line 21:
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Vascular medicine]]

Latest revision as of 16:00, 6 November 2019

Angiomyolipoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiomyolipoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angiomyolipoma risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiomyolipoma risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiomyolipoma risk factors

CDC on Angiomyolipoma risk factors

Angiomyolipoma risk factors in the news

Blogs on Angiomyolipoma risk factors

Directions to Hospitals Treating Angiomyolipoma

Risk calculators and risk factors for Angiomyolipoma risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Faizan Sheraz, M.D. [2], Rekha, M.D.

Overview

Tuberous sclerosis is a risk factor for the development of angiomyolipoma. Approximately 50% of individuals with tuberous sclerosis develop bilateral angiomyolipomas.

Risk Factors

Common Risk Factors

References

  1. Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, Roach ES (1998). "Renal lesion growth in children with tuberous sclerosis complex". J Urol. 160 (1): 141–5. PMID 9628635.
  2. Casper KA, Donnelly LF, Chen B, Bissler JJ (2002). "Tuberous sclerosis complex: renal imaging findings". Radiology. 225 (2): 451–6. doi:10.1148/radiol.2252011584. PMID 12409579.
  3. Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA (2006). "Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors". Kidney Int. 70 (10): 1777–82. doi:10.1038/sj.ki.5001853. PMID 17003820.
  4. Ewalt DH, Sheffield E, Sparagana SP, Delgado MR, Roach ES (1998). "Renal lesion growth in children with tuberous sclerosis complex". J Urol. 160 (1): 141–5. PMID 9628635.

Template:WikiDoc Sources